Former NIH chief Varmus to head National Cancer Institute

The New York Times: "Dr. Harold E. Varmus, a Nobel Prize-winning biologist and former director of the National Institutes of Health, will become director of the National Cancer Institute, the White House announced Monday. President Obama selected Dr. Varmus, who is now president of Memorial Sloan-Kettering Cancer Center in New York, after a lengthy search. Dr. Varmus is expected to shake up the much-criticized federal cancer program" (Pear, 5/17).

The Washington Post: "Although it is unusual for someone who once headed the entire NIH to return to run one of its member institutes, colleagues said the move offers Varmus the chance to have maximal impact on the field of cancer research at a unique moment in its history. ... As respected for his political savvy as he is for his scientific accomplishments, Varmus oversaw the doubling of the NIH's budget during his tenure as its director, from 1993 to 1999. Now, with the cost of cancer research galloping ahead of federal funding, [Edward] Benz [President of Dana Farber] and other supporters said they are hoping Varmus can tap his extensive Washington network to drum up more resources" (Aizenman, 5/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover why the TP53 gene is especially prone to mutations in cancer